Obesity - Page 2

April 1

Should you microdose Ozempic? Experts are split on risks vs benefits

Microdosing GLP-1 drugs is trending on social media and supported by some doctors, but experts warn the practice lacks a standard protocol and may undermine weight-loss results.

April 1

Weight-loss drugs crush food demand as farmers face dumping mountains of potatoes

Potato farmers report a massive surplus as weight-loss medication use cuts food demand. One farmer has 1.3 million pounds worth about $158,000 at risk of spoiling.

March 30

Doctor reveals secrets to lasting weight loss without counting calories

A kidney specialist explains why overeating is driven by hunger, not just calories, and shares strategies to manage cravings and improve long-term weight loss.

March 28

Hormone therapy boosts weight loss drug results by 35% in women, study finds

A Mayo Clinic study suggests postmenopausal women lost 35% more weight combining hormone therapy with tirzepatide, though experts urge caution on the findings.

March 24

New stronger weight-loss drug gets green light from FDA: 'Major jump'

The FDA approved Wegovy HD, a higher-dose semaglutide for weight loss in adults with obesity, offering greater weight reduction, as experts warn of side effects.

March 24

Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds

Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular risk by 22%, a new study finds.

March 18

Stopping Ozempic? New study reveals surprising weight regain results after GLP-1s

New research challenges fears about Ozempic weight regain. Cleveland Clinic study of 8,000 patients finds minimal rebound after stopping GLP-1 medications.

March 9

RFK Jr calls out popular chains over high-sugar coffee drinks: What's really in your cup?

Robert F. Kennedy Jr. is challenging Starbucks and Dunkin' over the sugar content in popular frozen coffee drinks, with medical experts sharing health warnings.

March 7

GLP-1 drugs linked to higher fracture risk, osteoporosis and gout, new studies suggest

A new study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with Type 2 diabetes compared to other diabetes medications.

February 21

DR MARC SIEGEL: RFK Jr and David Kessler are right to take on Big Food

Former FDA Commissioner David Kessler and HHS Secretary Robert F. Kennedy Jr. unite against ultra-processed foods despite their political differences.